Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Free Cash Flow (2016 - 2026)

Healthequity has reported Free Cash Flow over the past 14 years, most recently at $119.5 million for Q1 2026.

  • Quarterly results put Free Cash Flow at $119.5 million for Q1 2026, up 54.33% from a year ago — trailing twelve months through Jan 2026 was $457.1 million (up 34.51% YoY), and the annual figure for FY2026 was $457.1 million, up 34.51%.
  • Free Cash Flow for Q1 2026 was $119.5 million at Healthequity, down from $137.8 million in the prior quarter.
  • Over the last five years, Free Cash Flow for HQY hit a ceiling of $151.1 million in Q3 2025 and a floor of -$6.6 million in Q2 2022.
  • Median Free Cash Flow over the past 5 years was $53.4 million (2022), compared with a mean of $67.9 million.
  • Biggest five-year swings in Free Cash Flow: crashed 142.45% in 2022 and later surged 443.63% in 2023.
  • Healthequity's Free Cash Flow stood at $45.3 million in 2022, then rose by 26.46% to $57.3 million in 2023, then surged by 99.13% to $114.1 million in 2024, then increased by 20.74% to $137.8 million in 2025, then fell by 13.24% to $119.5 million in 2026.
  • The last three reported values for Free Cash Flow were $119.5 million (Q1 2026), $137.8 million (Q4 2025), and $151.1 million (Q3 2025) per Business Quant data.